Core Viewpoint - Jiangsu Aoyang Health Industry Co., Ltd. has completed the transfer of 20% of its shares to Zhangjiagang Yuesheng Technology Partnership, marking a shift from private to local state-owned control, which may enhance its market position and client trust [1][2][3] Group 1: Share Transfer Details - Aoyang Health's original controlling shareholder, Aoyang Group, transferred 20% of its shares, totaling 153 million shares, at a price of 3.87 yuan per share, amounting to a total of 593 million yuan [1] - The transfer was officially completed on November 6, 2025, with the new controlling entity being Zhangjiagang Economic and Technological Development Zone Management Committee [1] Group 2: Financial Performance - In the first three quarters of 2025, Aoyang Health reported a net profit attributable to shareholders of 40.11 million yuan, a year-on-year increase of 3.71% [2] - The net profit for the third quarter reached 8.56 million yuan, a significant increase of 533.86% compared to the same period last year, marking a new high for recent years [2] Group 3: Strategic Implications of Control Change - The change in control to a local state-owned entity may provide Aoyang Health with enhanced credibility and trust from clients, particularly those with government collaboration interests [2] - The new controlling entity's diverse industry background could facilitate resource integration, potentially enhancing Aoyang Health's capabilities in areas like remote healthcare and smart health monitoring [3] - The shift aligns with national policies promoting integrated medical and elderly care, positioning Aoyang Health to leverage new market opportunities and improve competitive advantage [3]

Core Insights - The company has achieved significant growth in profitability, with a net profit of 8.56 million yuan in Q3 2025, marking a substantial increase of 533.86% year-on-year, reaching a new high for the same period in recent years [1] - For the first three quarters of 2025, the cumulative net profit attributable to shareholders reached 40.11 million yuan, reflecting a year-on-year growth of 3.71%, demonstrating strong operational resilience despite short-term revenue adjustments [1] - The company’s core business profitability has improved, with a net profit of 2.35 million yuan in Q3 2025, up 63.23% year-on-year, indicating a substantial enhancement in core business performance [1] Profitability and Efficiency - The gross profit margin for the first three quarters of 2025 remained stable at 14.27%, while the net profit margin in Q3 increased to 1.91%, up 1.57 percentage points year-on-year, showcasing improved profitability quality during revenue structure adjustments [2] - The company has established a medical consortium centered around Aoyang Hospital, with over 2,300 total beds, covering comprehensive medical and rehabilitation services, thus forming a strong competitive advantage in the regional healthcare market [2] Shareholding Changes - The company’s shareholding change has been a focal point, with the controlling shareholder, Aoyang Group, transferring 20% of its shares to Zhangjiagang Yuesheng Technology Co., Ltd. for a total price of 593 million yuan, which has been completed [3] - Following the change in control, the new shareholder is expected to provide policy resource support, expand financing channels, and enhance regional business collaboration, thereby optimizing the company’s governance structure and strengthening its capital base for future development [3]

江苏澳洋健康产业股份有限公司 关于控股股东协议转让股份完成过户登记暨公司控股股东、实际控制人变更的公告 证券代码：002172 证券简称：澳洋健康 公告编号：2025-34 关于控股股东协议转让股份完成过户登记暨公司 控股股东、实际控制人变更的公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，对公告的虚 假记载、误导性陈述或者重大遗漏负连带责任。 江苏澳洋健康产业股份有限公司（以下简称"澳洋健康"或"公司"）于 今日收到张家港悦升科技合伙企业（有限合伙）（以下简称"悦升科技"）的通 知，获悉其协议转让公司股份事宜已完成过户登记手续。具体情况如下： 一、本次交易的基本情况 公司原控股股东澳洋集团有限公司（以下简称"澳洋集团"）、实际控制人 沈学如、实际控制人的一致行动人沈卿于 2025 年 9 月 15 日与张家港悦升科技合 伙企业（有限合伙）签署了《股份转让协议》。澳洋集团拟通过协议转让方式转 让公司 20%股份，共计 153,146,472 股。转让价格为 3.87 元/股，合计总金额为 592,676,846.64 元。 本次权益变动不构成关联交易，不触及要约收购。本次权益变动完成后，悦 升科技 ...

Group 1 - The core point of the article is that Aoyang Health announced the release of a portion of shares pledged by its major shareholder, Aoyang Group, amounting to 15,000,000 shares [2] Group 2 - Aoyang Group holds more than 5% of Aoyang Health's shares [2] - The announcement was made on the evening of November 6 [2]

Core Viewpoint - Aoyang Health has completed the transfer of shares to Yue Sheng Technology, resulting in a change of controlling shareholder and actual controller [1] Group 1: Share Transfer Details - Aoyang Health announced that it received notification from Zhangjiagang Yue Sheng Technology Partnership (Limited Partnership) regarding the completion of the share transfer registration [1] - Following the completion of the share transfer, the controlling shareholder of Aoyang Health has changed from Aoyang Group to Yue Sheng Technology [1] - The actual controller of the company has changed from Shen Xueru to the Management Committee of Zhangjiagang Economic and Technological Development Zone [1]

Core Points - The announcement from Aoyang Health indicates a significant change in its ownership structure, with Aoyang Group transferring 20% of its shares to Yuesheng Technology [1] - The share transfer involves 153,146,472 shares at a price of 3.87 yuan per share, totaling approximately 592.68 million yuan [1] - Following the transfer, Yuesheng Technology will hold 20% of the company's total shares, and the controlling shareholder will shift from Aoyang Group to Yuesheng Technology, with the actual controller changing to the Zhangjiagang Economic and Technological Development Zone Management Committee [1] Summary by Sections - **Ownership Change** - Aoyang Group is transferring 20% of its shares to Yuesheng Technology, resulting in a new controlling shareholder [1] - The actual controller will change from Shen Xueru to the Zhangjiagang Economic and Technological Development Zone Management Committee [1] - **Financial Details** - The share transfer involves 153,146,472 shares priced at 3.87 yuan each, amounting to a total of 592,676,846.64 yuan [1] - The transaction does not constitute a related party transaction and does not trigger a mandatory tender offer [1] - **Completion of Transfer** - The transfer of shares has been completed, and the company has received notification of the successful registration of the transfer [1]

Core Points - Aoyang Health (SZ 002172) announced the completion of a share transfer, with 153,146,472 shares (20.00% of total shares) transferred to Zhangjiagang Yuesheng Technology Partnership, changing the controlling shareholder from Aoyang Group to Yuesheng Technology [1] - The actual controller of the company has changed from Shen Xueru to the Management Committee of Zhangjiagang Economic and Technological Development Zone [1] - For the first half of 2025, Aoyang Health's revenue composition was 52.49% from medical services and 47.51% from pharmaceutical logistics [1] - As of the announcement, Aoyang Health's market capitalization is 3.4 billion yuan [1]

Core Points - Aoyang Health announced that Yuesheng Technology has acquired a 20% stake in the company for a total amount of 593 million yuan [1] - Following this equity change, Yuesheng Technology will hold 153 million shares, representing 20.00% of the company's total share capital [1] - The controlling shareholder will change from Aoyang Group to Yuesheng Technology, and the actual controller will change from Shen Xueru to the Management Committee of Zhangjiagang Economic and Technological Development Zone [1]

Core Viewpoint - The announcement indicates that a major shareholder, Aoyang Group, has released part of its pledged shares in Aoyang Health, which may reflect a shift in the shareholder's strategy or confidence in the company's future performance [1] Summary by Categories Shareholder Actions - Aoyang Group has released 15 million shares from pledge, which accounts for 18.25% of its total holdings and 1.96% of the company's total share capital [1] - The pledge was initiated on December 13, 2023, and the release date is set for November 3, 2025 [1] Current Pledge Status - As of the announcement date, the total number of pledged shares by the company's shareholders and their concerted actions amounts to 79.93% of their total holdings [1]

江苏澳洋健康产业股份有限公司 关于公司股东部分股份解除质押的公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，对公告的虚 假记载、误导性陈述或者重大遗漏负连带责任。 江苏澳洋健康产业股份有限公司（以下简称"澳洋健康"或"公司"）近日接到 持股 5%以上股东澳洋集团有限公司（以下简称"澳洋集团"）的通知，获悉澳洋 集团所持有公司的部分股份解除质押，具体事项如下： 关于公司股东部分股份解除质押的公告 证券代码：002172 证券简称：澳洋健康 公告编号：2025-35 截至公告披露日，上述股东及其一致行动人所持质押股份情况如下： | | | | | | | 已质押股份 | | 未质押股份 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | | 累计质押/ | 占其所 | 占公司 | 情况 | | 情况 | | | 股东名 称 | 持股数量 （股） | 持股比 例 | 冻结/拍卖 等数量（股） | 持股份 比例 | 总股本 比例 | 已质押 股份限 售和冻 | 占已质 押股份 | 未质押股 份限售和 | 占未质押 ...